Abstract: Background: Substance Use Disorders (SUDs) are linked with significant cognitive, behavioral and psychosocial impairments, such as deficits in executive functioning, attention, working memory and decision making. These impairments negatively impact treatment adherence and relapse prevention. Emerging evidence also indicates that maladaptive personality characteristics, particularly Dark Triad traits (Machiavellianism, narcissism and psychopathy), may contribute to substance use behaviors, poor self-regulation, resistance to treatment and vulnerability to relapse...
Key words- Substance Use Disorders, Dark Triad, Machiavellianism, Narcissism, Psychopathy, Cognitive Rehabilitation, Psychosocial Rehabilitation, Addiction Recovery.
[1].
Brooks, S. J., Wiemerslage, L., Burch, K. H., Maiorana, S. A., Cocolas, E., Schiöth, H. B., … & Stein, D. J. (2017). The impact of cognitive training in substance use disorder: The effect of working memory training on impulse control in methamphetamine users. Psychopharmacology, 234(12), 1911–1921.
[2].
Caetano, T., Pinho, M. S., Ramadas, E., Clara, C., Areosa, T., & Dixe, M. D. A. (2021). Cognitive training effectiveness on memory, executive functioning, and processing speed in individuals with substance use disorders: A systematic review. Frontiers in Psychology, 12, 730165.
[3].
Jerlhag, E., & Engel, J. A. (2011). Ghrelin receptor antagonism attenuates nicotine-induced locomotor stimulation, accumbal dopamine release and conditioned place preference in mice. Drug and Alcohol Dependence, 117(2–3), 126–131.
[4].
Khemiri, L., Brynte, C., Stunkel, A., Klingberg, T., & Jayaram-Lindström, N. (2019). Working memory training in alcohol use disorder: A randomized controlled trial. Alcoholism: Clinical and Experimental Research, 43(1), 135–146.
[5].
Kiluk, B. D., Nich, C., Buck, M. B., Devore, K. A., Frankforter, T. L., LaPaglia, D. M., … & Carroll, K. M. (2018). Randomized clinical trial of computerized cognitive behavioral therapy and clinician-delivered CBT in comparison with standard outpatient treatment for substance use disorders: Primary within-treatment and follow-up outcomes. American Journal of Psychiatry, 175(9), 853–863.